Global Market Eye

  Surging prevalence of diabetes and growing awareness among patients regarding the treatment options available are the key factors propelling the   global insulin delivery devices market . In a recent report titled “Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020”, Persistence Market Research states that the market for insulin delivery devices is anticipated to expand at a healthy CAGR of 7.0% from 2014 to 2020. If this holds true, the value of the global market will rise from US$9,391.1 mn in 2014 to US$14,093.3 mn by 2020. Even with the increasing number of factors fueling the insulin delivery devices market, high cost of insulin analog and complications and risks associated with the delivery of insulin are anticipated to impede the growth of the global market. However, trends such as development of home infusion therapy and artificial pancreas are gaining popularity, which is sure to boost the insulin delivery devices market in the coming yea

  According to a new market report published by Persistence Market Research “Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020,” the   global ophthalmic devices market   was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020. Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market. However, lack of awareness among people about eye disorders, poor primary healthcare infrastructure, and lack of insurance in developing countries hamper growth of the global ophthalmic devices market. In addition, eye

  Persistence Market Research delivers the key insights on the global dental CAD/CAM & dental prosthesis market in its upcoming report titled “ Dental CAD/CAM & Dental Prosthesis Market : Global Industry Analysis 2013–2017 and Forecast 2018 – 2026”. In terms of revenue, the global dental CAD/CAM & dental prosthesis market is projected to register a  CAGR of 5.6%  over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecast. The dental CAD/CAM & dental prosthesis market is expected to record a year-over-year growth rate of 5.6% by 2026. The dental CAD/CAM & dental prosthesis market is segmented based on product type, end users and regions. By product type, the dental CAD/CAM & dental prosthesis market is segmented into; dental prosthesis and dental CAD/CAM system. Strategizing The Moves For The Next Decade? See Through Sample Of Dental Cad Cam Dental Prosthesis Market Report!  https://www.persistencemarketresearch.

  Persistence Market Research (PMR) delivers the key insights on the global dental X-ray systems market in its upcoming report titled “Dental X-ray Systems Market: Global Industry Analysis 2013–2017 and Forecast 2018 – 2026”. In terms of revenue, the  global dental X-ray systems market  is expected to grow at a promising CAGR of 6.4% during 2018 – 2026. North America is anticipated to contribute a major share in terms of revenue in the global dental X-ray systems market over the forecast period. With an expected value share of around 35%-40% in 2017, the North America dental X-ray systems market is projected to reach US$ 1,111.4 Mn by the end of 2026. To remain ‘ahead’ of your competitors, request for a Sample@   https://www.persistencemarketresearch.com/samples/24586 The global dental X-ray systems market is segmented based on product type, end users, and regions. Based on product type, the dental X-ray systems market is segmented into Dental X-Ray Systems and Cone-Beam Computed Tomog

  The global market for high content screening is currently witnessing the emergence of several notable trends from the product, application, and industry perspective. Growing concerns of pharmaceutical companies towards toxicity studies is shifting focus on secondary cell screening. Further, biotechnology and pharmaceutical companies are deploying high content screening solutions for effective risk assessment of critical illnesses to facilitate efficient drug discovery. Manufacturers in the high content screening market are offering advanced instruments to facilitate various lab services. How About Looking Through The Sample Of High Content Screening Market Report?  https://www.persistencemarketresearch.com/samples/12931 Company Profiles Becton, Dickinson and Company Thermo Fisher Scientific Inc. GE Healthcare Olympus Corporation PerkinElmer Inc. Merck Millipore Corporation Danaher Corporation (Molecular Devices) Yokogawa Electric Corporation Sysmex Corporation Others. These factors a

  Over the years, significant advancements and investments in life science research and growth in industrial-level automation have led to improvements in various systems and processes used in life sciences research and development. Labeling of research specimens has moved from tedious, labor-intensive manual forms to a more automated version that enhances productivity, minimizes the chances of errors, reduces costs, and provides more control over lab workflows. Automatic tube labeling systems are more in vogue today, riding on laboratory automation to provide the desired output with increased efficiency to systematically track samples. Get Going With Sample Of Automatic Tube Labelling System Market Report!  https://www.persistencemarketresearch.com/samples/16222 Company Profile Computype Inc. PaR Systems, Inc. AutoLabe Scinomix Inc. ALTECH Srl Brooks Automation, Inc. BioMicroLab Inc. California Advanced Labeling, Inc. HTI bio-X GmbH Capmatic Ltd. Others. This is fueling revenue growth

  Increasing consumer spending on aesthetic treatments coupled with growing popularity of non-surgical procedures are key factors driving the global facial rejuvenation market. Macro factors including rising employability and promising economic growth in Asia Pacific to promote nice-to-have services are projected to contribute to the adoption of facial rejuvenation treatments and present potential growth opportunities to providers and other stakeholders in the facial rejuvenation market. As per a report by Persistence Market Research (PMR), the global facial rejuvenation market, expanding at a steady  5.0% CAGR , is likely to reach a valuation of  US$ 39.4 Bn by 2028 . However, adverse reactions associated with facial aesthetics products, high procedure costs, and lack of trained professionals are some key factors projected to restrain the adoption of facial rejuvenation procedures. Planning Forward? Access Sample Of Facial Rejuvenation Market Report!  https://www.persistencemarketrese

  In a recently published market research study, Persistence Market Research presents a detailed opportunity analysis of the  global anticancer drugs market , revealing key factors likely to have a significant impact on revenue growth of the anticancer drugs market in the next few years. Over the years, there has been an increasing emphasis on R&D in drug development and therapies for the treatment of different types of cancer. Pharmaceutical companies are introducing novel drug formulations in the global market, thereby expanding the product pipeline for cancer treatment. This is likely to create newer vistas of growth in the anticancer drugs market. Strategizing The Moves For The Next Decade? See Through Sample Of Anticancer Drugs Market Report!  https://www.persistencemarketresearch.com/samples/24355 Company Profiles F. Hoffmann-La Roche Ltd Roche Holding AG Celgene Corp Novartis AG Bristol-Myers Squibb Co Johnson & Johnson Merck & Co. Eli Lilly and Company AstraZeneca p

  In a recent study on the global  uterine cancer diagnostic testing market , leading research firm Persistence Market Research has tracked the growth path of the global market for uterine cancer diagnostic testing over an eight year period from 2018 to 2026. The report features global market numbers and insights on the various factors driving the adoption of advanced uterine cancer diagnostic tests. According to the report, two of the main aspects responsible for a surge in revenue in the global uterine cancer diagnostic testing market are – a rising awareness among the female population pertaining to the various diseases of the uterus, and the availability of different types of direct and combination tests to detect uterine cancer. How About Looking Through The Sample Of Uterine Cancer Diagnostic Testing Market Report?  https://www.persistencemarketresearch.com/samples/17005 Company Profiles  Abbott Roche Holdings AG Siemens AG Danaher BioMerieux SA How About Step-By-Step Insights To